| 609088 |
NEURO-ONCOLOGY |
EXTH-39. HEXON SWAPPING MITIGATES ANTI-VIRAL IMMUNE RESPONSE DURING BRAIN TUMOR VIROTHERAPY | EXTH-39. HEXON SWAPPING MITIGATES ANTI-VIRAL IMMUNE RESPONSE DURING BRAIN TUMOR VIROTHERAPY |
2020-11-01 |
10.1093/neuonc/noaa215.393 |
Ho Shin Dong, Nguyen Teresa, Jiang Hong, Sohoni Sagar, Gupta Sumit, Ossimetha Ashley, Alonso Marta M, Gomez-Manzano Candelaria, Fueyo Juan |
| 609087 |
NEURO-ONCOLOGY |
TAMI-20. POLY(ADP-RIBOSE) GLYCOHYDROLASE INHIBITION SEQUESTERS NAD+ TO POTENTIATE THE METABOLIC LETHALITY OF ALKYLATING CHEMOTHERAPY IN IDH MUTANT TUMOR CELLS | TAMI-20. POLY(ADP-RIBOSE) GLYCOHYDROLASE INHIBITION SEQUESTERS NAD+ TO POTENTIATE THE METABOLI |
2020-11-01 |
10.1093/neuonc/noaa215.909 |
Nagashima Hiroaki, Lee Christine, Tateishi Kensuke, Higuchi Fumi, Subramanian Megha, Rafferty Seamus, Melamed Lisa, Miller Julie, Wakimoto Hiroaki, Cahill Daniel |
| 609086 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
821 Class specific HDAC inhibition differentially affects the function of specific T cell subsets |
2020-11-01 |
10.1136/jitc-2020-sitc2020.0821 |
Holay Nisha, Giri Uma, Berg Carla Van Den, Eckhardt Gail, Triplett Todd |
| 609085 |
INDIAN HEART JOURNAL : OFFICIAL PUBLICATION OF THE CARDIOLOGICAL SOCIETY OF INDIA |
Impact of seasonal variation in HF patients |
2020-11-01 |
10.1016/j.ihj.2020.11.063 |
Singh Bupinder |
| 609084 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Radio-sensitizing effect of a cocktail of phytochemicals on HepG2 cell proliferation, motility and survival |
2020-11-01 |
10.1016/j.biopha.2020.110620 |
Abdraboh Mohamed E., Essa Zaidoon Shaker, Abdelrazzak Abdelrazek B., El-Far Yousra M., Elsherbini Yasser, El-Zayat Mustafa M., Ali Doaa A. |
| 609083 |
BMJ OPEN |
Association between platelet count and hepatocellular carcinoma overall survival: a large retrospective cohort study |
2020-11-01 |
10.1136/bmjopen-2020-038172 |
Lu Linbin, Su Zhimin, Zheng Peichan, Wu Zhixian, Zhang Yan, He Huimin, Liu Jingnan, Lin Shan, Chen Xiong |
| 609082 |
NEURO-ONCOLOGY |
COVD-29. CONTINUATION OF TEMOZOLOMIDE CHEMOTHERAPY IN A GLIOBLASTOMA PATIENT AFTER RESOLUTION OF COVID-19 PNEUMONIA |
2020-11-01 |
10.1093/neuonc/noaa215.110 |
Thakkar Jigisha, Teitcher Michael, Anderson Douglas, Barton Kevin, Melain Edward |
| 609081 |
NEURO-ONCOLOGY |
CBIO-22. p53 GAIN-OF-FUNCTION MUTATIONS DRIVE SEX SPECIFIC EFFECTS ON GLIOMA TUMORIGENESIS | CBIO-22. p53 GAIN-OF-FUNCTION MUTATIONS DRIVE SEX SPECIFIC EFFECTS ON GLIOMA TUMORIGENESIS |
2020-11-01 |
10.1093/neuonc/noaa215.082 |
Rockwell Nathan, Warrington Nicole, Rubin Joshua |
| 609080 |
NEURO-ONCOLOGY |
CTIM-31. USE OF A SINGLE PEPTIDE CHECKPOINT INHIBITOR FOR TREATMENT OF CENTRAL NERVOUS SYSTEM TUMORS | CTIM-31. USE OF A SINGLE PEPTIDE CHECKPOINT INHIBITOR FOR TREATMENT OF CENTRAL NERVOUS SYSTEM TUMORS |
2020-11-01 |
10.1093/neuonc/noaa215.165 |
Moertel Christopher, Xiong Zhengming, Zellmer David, Pluhar Elizabeth, Neil Elizabeth, Greengard Emely, Olin Michael |
| 609079 |
NEURO-ONCOLOGY |
NCOG-44. NEUROLOGIC ASSESSMENT IN NEURO-ONCOLOGY (NANO) SCALE IN A PHASE II STUDY OF PEMBROLIZUMAB OR PEMBROLIZUMAB PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA | NCOG-44. NEUROLOGIC ASSESSMENT IN NEURO-ONCOLOGY (NANO) SCALE IN A PHASE II STUD |
2020-11-01 |
10.1093/neuonc/noaa215.582 |
Nayak Lakshmi, Molinaro Annette, Peters Katherine, Clarke Jennifer, Jordan Justin, de Groot John, Nghiemphu Phioanh, Kaley Thomas, Colman Howard, McCluskey Christine, Gaffey Sarah, Smith Timothy, Cote David, Severgnini Mariano, Yearley Jennifer, Zhao Qing, Blumenschein Wendy, Duda Gabriel, Muzikansky Alona, Jain Rakesh, Wen Patrick, Reardon David |
